Begins Coverage on Veradigm (NASDAQ:MDRX) started coverage on shares of Veradigm (NASDAQ:MDRXGet Free Report) in a research note issued on Tuesday. The brokerage set a “hold” rating on the software maker’s stock.

Separately, Stephens restated an “equal weight” rating and set a $13.00 price objective on shares of Veradigm in a report on Tuesday, October 10th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $19.36.

Get Our Latest Stock Analysis on MDRX

Veradigm Stock Performance

Shares of MDRX stock opened at $13.20 on Tuesday. The company has a market cap of $1.44 billion, a P/E ratio of 30.70 and a beta of 0.87. The stock has a 50 day simple moving average of $13.16 and a two-hundred day simple moving average of $12.77. Veradigm has a fifty-two week low of $11.30 and a fifty-two week high of $19.77.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Cerity Partners LLC purchased a new position in Veradigm in the first quarter worth $804,000. Pinebridge Investments L.P. purchased a new position in Veradigm in the second quarter worth $26,000. Gladius Capital Management LP purchased a new position in Veradigm in the first quarter worth $28,000. Quadrant Capital Group LLC boosted its position in Veradigm by 200.5% in the second quarter. Quadrant Capital Group LLC now owns 2,263 shares of the software maker’s stock worth $29,000 after purchasing an additional 1,510 shares during the last quarter. Finally, Quarry LP purchased a new position in Veradigm in the first quarter worth $37,000.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with's FREE daily email newsletter.